Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice

Journal of Lipid Research

Volumn 49, Issue 4, 2008, Pages 773-781

  Shelly, Lorraine ^a   Royer, Lori ^a   Sand, Thomas ^a   Jensen, Heather ^a   Luo, Yi ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

ATP binding cassette transporter G5; ATP binding cassette transporter G8; Cholesterol absorption

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER G5; ABC TRANSPORTER G8; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; PHOSPHOLIPID TRANSFER PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROGENESIS; BILE SECRETION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; INFLAMMATION; INTESTINE ABSORPTION; KNOCKOUT MOUSE; LIPID ABSORPTION; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE; ANIMAL; ANIMAL FOOD; BLOOD; C57BL MOUSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; LIVER; METABOLISM; MOUSE MUTANT;

ANIMAL FEED; ANIMALS; AORTA; GENE EXPRESSION REGULATION; GENOTYPE; HYPERCHOLESTEROLEMIA; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LIPIDS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOLIPID TRANSFER PROTEINS;

EID: 44949200469     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700336-JLR200     Document Type: Article

References (50)

1. Tall, A. R., and F. Lalanne. 2003. Phospholipid transfer protein and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23: 1484-1485.
2. Tollefson, J. H., S. Ravnik, and J. J. Albers. 1988. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J. Lipid Res. 29: 1593-1602.
3. Day, J. R., J. J. Albers, C. E. Lofton-Day, T. L. Gilbert, A. F. Ching, F. J. Grant, P. J. O'Hara, S. M. Marcovina, and J. L. Adolphson. 1994. Complete cDNAencoding human phospholipid transfer protein from human endothelial cells. J. Biol. Chem. 269: 9388-9391.
4. Tall, A. R., S. Krumholz, T. Olivecrona, and R. J. Deckelbaum. 1985. Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. J. Lipid Res. 26: 842-851.
5. Jauhiainen, M., J. Metso, R. Pahlman, S. Blomqvist, A. van Tol, and C. Ehnholm. 1993. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J. Biol. Chem. 268: 4032-4036.
6. Huuskonen, J., V. M. Olkkonen, C. Ehnholm, J. Metso, I. Julkunen, and M. Jauhiainen. 2000. Phospholipid transfer is a prerequisite for PLTP-mediated HDL conversion. Biochemistry. 39: 16092-16098.
7. Lagrost, L., C. Desrumaux, D. Masson, V. Deckert, and P. Gambert. 1998. Structure and function of the plasma phospholipid transfer protein. Curr. Opin. Lipidol. 9: 203-209.
8. Schlitt, A., C. Bickel, P. Thumma, S. Blankenberg, H. J. Rupprecht, J. Meyer, and X. C. Jiang. 2003. High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 23: 1857-1862.
9. de Vries, R., G. Dallinga-Thie, A. Smit, B. Wolffenbuttel, A. van Tol, and R. Dullaart. 2006. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus. Diabetologia. 49: 398-404.
10. Jiang, X. C., S. Qin, C. Qiao, K Kawano, M. Lin, A. Skold, X. Xiao, and A. R. Tall. 2001. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat. Med. 7: 847-852.
11. van Haperen, R., A. van Tol, T. van Gent, L. Scheek, P. Visser, A. van der Kamp, F. Grosveld, and R. de Crom. 2002. Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. J. Biol. Chem. 277: 48938-48943.
12. Yang, X. P., D. Yan, C. Qiao, R. J. Liu, J. G. Chen, J. Li, M. Schneider, L. Lagrost, X. Xiao, and X. C. Jiang. 2003. Increased atherosclerotic lesions in apoE mice with plasma phospholipid transfer protein overexpression. Arterioscler. Thromb. Vasc. Biol. 23: 1601-1607.
13. Jiang, X. C., C. Bruce, J. Mar, M. Lin, Y. Ji, O. L. Francone, and A. R. Tall. 1999. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J. Clin. Invest. 103: 907-914.
14. Kawano, K., S. Qin, C. Vieu, X. Collet, and X. C. Jiang. 2002. Role of hepatic lipase and scavenger receptor BI in clearing phospholipid/ free cholesterol-rich lipoproteins in PLTP-deficient mice. Biochim. Biophys. Acta. 1583: 133-140.
15. Jiang, X. C., A. R. Tall, S. Qin, M. Lin, M. Schneider, F. Lalanne, V. Deckert, C. Desrumaux, A. Athias, J. L. Witztum, et al. 2002. Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. J. Biol. Chem. 277: 31850-31856.
16. Yan, D., M. Navab, C. Bruce, A M. Fogelman, and X. C. Jiang. 2004. PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity. J. Lipid Res. 45: 1852-1858.
17. Libby, P. 2002. Inflammation in atherosclerosis. Nature. 420: 868-874.
18. Francone, O. L., M. Haghpassand, J. A. Bennett, L. Royer, and J. McNeish. 1997. Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport. J. Lipid Res. 38: 813-822.
19. Li, X., F. Catalina, S. M. Grundy, and S. Patel. 1996. Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48- relative to B-100-containing lipoproteins. J. Lipid Res. 37: 210-220.
20. Riddle, T. M., N. M. Schildmeyer, C. Phan, C. J. Fichtenbaum, and D. Y. Hui. 2002. The HIV protease inhibitor ritonavir increases lipoprotein production and has no effect on lipoprotein clearance in mice. J. Lipid Res. 43: 1458-1463.
21. Yu, L., J. Li-Hawkins, R. E. Hammer, K. E. Berge, J. D. Horton, J. C. Cohen, and H. H. Hobbs. 2002. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J. Clin. Invest. 110: 671-680.
22. Zibara, K., E. Chignier, C. Covacho, R. Poston, G. Canard, P. Hardy, and J. McGregor. 2000. Modulation of expression of endothelial intercellular adhesion molecule-1, platelet-endothelial cell adhesion molecule-1, and vascular cell adhesion molecule-1 in aortic arch lesions of apolipoprotein E-deficient compared with wild-type mice. Arterioscler. Thromb. Vasc. Biol. 20: 2288-2296.
23. Bro, S., F. Moeller, C. B. Andersen, K. Olgaard, and L. B. Nielsen. 2004. Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice. J. Am. Soc. Nephrol. 15: 1495-1503.
24. Nakashima, Y., E. W. Raines, A. S. Plump, J. L. Breslow, and R. Ross. 1998. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis- prone sites on the endothelium in the apoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18: 842-851.
25. Dansky, H. M., C. B. Barlow, C. Lominska, J. L. Sikes, C. Kao, J. Weinsaft, M. I. Cybulsky, and J. D. Smith. 2001. Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler. Thromb. Vasc. Biol. 21: 1662-1667.
26. Nageh, M. F., E. T. Sandberg, K. R. Marotti, A. H. Lin, E. P. Melchior, D. C. Bullard, and A. L. Beaudet. 1997. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 17: 1517-1520.
27. Qin, S., K. Kawano, C. Bruce, M. Lin, C. Bisgaier, A. R. Tall, and X. Jiang. 2000. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins. J. Lipid Res. 41: 269-276.
28. Pitas, R. E., T. L. Innerarity, K. S. Arnold, and R. W. Mahley. 1979. Rate and equilibrium constants for binding of apo-E HDLc (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: evidence for multiple receptor binding of apo-E HDLc. Proc. Natl. Acad. Sci. USA. 76: 2311-2315.
29. Yokode, M., R. E. Hammer, S. Ishibashi, M. S. Brown, and J. L. Goldstein. 1990. Diet-induced hypercholesterolemia in mice: prevention by overexpression of LDL receptors. Science. 250: 1273-1275.
30. Temel, R. E., W. Tang, Y. Ma, L. L. Rudel, M. C. Willingham, Y. A. Ioannou, J. P. Davies, L. M. Nilsson, and L. Yu. 2007. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J. Clin. Invest. 117: 1968-1978.
31. Covey, S. D., M. Krieger, W. Wang, M. Penman, and B. L. Trigatti. 2003. Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells. Arterioscler. Thromb. Vasc. Biol. 23: 1589-1594.
32. Ma, K., T. Forte, J. D. Otvos, and L. Chan. 2005. Differential additive effects of endothelial lipase and scavenger receptor-class B type I on high-density lipoprotein metabolism in knockout mouse models. Arterioscler. Thromb. Vasc. Biol. 25: 149-154.
33. Van Eck, M., M. Hoekstra, R. B. Hildebrand, Y. Yaong, D. Stengel, J. K. Kruijt, W. Sattler, U. J. F. Tietge, E. Ninio, T. J. C. Van Berkel, et al. 2007. Increased oxidative stress in scavenger receptor BI knockout mice with dysfunctional HDL. Arterioscler. Thromb. Vasc. Biol. 27: 2413-2419.
34. Vaisar, T., S. Pennathur, P. S. Green, S. A. Gharib, A. N. Hoofnagle, M. C. Cheung, J. Byun, S. Vuletic, S. Kassim, P. Singh, et al. 2007. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Invest. 117: 746-756.
35. Ishibashi, S., M. S. Brown, J. L. Goldstein, R. D. Gerard, R. E. Hammer, and J. Herz. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus- mediated gene delivery. J. Clin. Invest. 92: 883-893.
36. Henninger, D. D., M. E. Gerritsen, and D. N. Granger. 1997. Low- density lipoprotein receptor knockout mice exhibit exaggerated microvascular responses to inflammatory stimuli. Circ. Res. 81: 274-281.
37. Ostos, M. A., M. Conconi, L. Vergnes, N. Baroukh, J. Ribalta, J. Girona, J-M. Caillaud, A. Ochoa, and M. M. Zakin. 2001. Anti-oxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21: 1023-1028.
38. Qin, X., D. K. Swertfeger, S. Zheng, D. Y. Hui, and P. Tso. 1998. Apolipoprotein A-IV: a potent endogenous inhibitor of lipid oxidation. Am. J. Physiol. Heart Circ. Physiol. 274: H1836-H1840.
39. Liao, F., A. Andalibi, A. J. Lusis, and A. M. Fogelman. 1995. Genetic control of the inflammatory response induced by oxidized lipids. Am. J. Cardiol. 75: 65B-66B.
40. Liao, F., A. Andalibi, J. H. Qiao, H. Allayee, A. M. Fogelman, and A. J. Lusis. 1994. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J. Clin. Invest. 94: 877-884.
41. Vikstedt, R., D. Ye, J. Metso, R. B. Hildebrand, T. J. C. Van Berkel, C. Ehnholm, M. Jauhiainen, and M. Van Eck. 2007. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development. Arterioscler. Thromb. Vasc. Biol. 27: 578-586.
42. Liu, R., M. R. Hojjati, C. M. Devlin, I. H. Hansen, and X-C. Jiang. 2007. Macrophage phospholipid transfer protein deficiency and apoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27: 190-196.
43. Valenta, D. T., N. Ogier, G. Bradshaw, A. S. Black, D. J. Bonnet, L. Lagrost, L. K. Curtiss, and C. M. Desrumaux. 2006. Athero- protective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein A-I overexpression. Arterioscler. Thromb. Vasc. Biol. 26: 1572-1578.
44. Cheung, M. C., B. G. Brown, E. K. Marino Larsen, A. D. Frutkin, and K. D. O'Brien, and J. J. Albers. 2006. Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease. Biochim. Biophys. Acta. 1762: 131-137.
45. Wu, J. E., F. Basso, R. D. Shamburek, M. J. A. Amar, B. Vaisman, G. Szakacs, C. Joyce, T. Tansey, L. Freeman, B. J. Paigen, et al. 2004. Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice. J. Biol. Chem. 279: 22913-22925.
46. Yu,L.,R.E.Hammer,J.Li-Hawkins,K.vonBergmann, D. Lutjohann, J. C. Cohen, and H. H. Hobbs. 2002. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc. Natl. Acad. Sci. USA. 99: 16237-16242.
47. -/- mice. J. Lipid Res. 45: 1429-1436.
48. Duan, L-P., H. H. Wang, and D. Q. H. Wang. 2004. Cholesterol absorption is mainly regulated by the jejunal and ileal ATP-binding cassette sterol efflux transporters Abcg5 and Abcg8 in mice. J. Lipid Res. 45: 1312-1323.
49. Liu, R.,J. Iqbal, C. Yeang, D. Q. H. Wang, M. M. Hussain, and X-C. Jiang. 2007. Phospholipid transfer protein deficient mice absorb less cholesterol. Arterioscler. Thromb. Vasc. Biol. 27: 2014-2021.
50. Repa, J. J., K. E. Berge, C. Pomajzl, J. A. Richardson, H. Hobbs, and D. J. Mangelsdorf. 2002. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J. Biol. Chem. 277: 18793-18800.